Meghdad Abdollahpour-Alitappeh

20PUBLICATIONS
24CO-AUTHORS
BiomaterialsMolecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Physical education and development curriculum and pedagogy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Apr 10, 2024
Progress of antibody-drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studies.

Ali Hussein Mer, Yousef Mirzaei, Fatemeh Misamogooe

|Feb 26, 2024
Association of Y chromosome AZF region microdeletions with recurrent miscarriage in Iranian couples: A case-control study.

Nasrin Pazoki, Mitra Salehi, Seyed Abdolhamid Angaji

|Jul 09, 2021
Strengthening the CAR-T cell therapeutic application using CRISPR/Cas9 technology.

Muhammad Sadeqi Nezhad, Mahboubeh Yazdanifar, Meghdad Abdollahpour-Alitappeh

|Jun 11, 2021
Induced Pluripotent Stem Cells (iPSCs) Provide a Potentially Unlimited T Cell Source for CAR-T Cell Development and Off-the-Shelf Products.

Muhammad Sadeqi Nezhad, Meghdad Abdollahpour-Alitappeh, Behzad Rezaei

|Apr 12, 2021
Effects of exercise training on immunological factors in kidney transplant recipients; a randomized controlled trial.

Nazi Hemmati, Sohrab Kazemi, Narges Jamshidian-Tehrani

Pageof 4